Search results for Rabies virus

Human Rabies Virus IgG (RABV IgG) ELISA Kit, Abbexa, abx055449

Human Rabies Virus (RABV) IgG ELISA Kit is an ELISA kit against Rabies Virus IgG.

Dog Rabies Virus IgG (RABV IgG) ELISA Kit, Abbexa, abx055582

Dog Rabies virus (RABV) IgG ELISA Kit is an ELISA Kit against Dog Rabies virus IgG.

Rabies Virus Matrix Protein (RABV M) Antibody (Biotin), Abbexa, abx106357

Rabies Virus Matrix Protein (RABV M) Antibody (Biotin) is a Rabbit Polyclonal antibody against Rabies Virus Matrix Protein (RABV M) conjugated to Biotin.

Rabies Virus Protein C (RABV C) Antibody (Biotin), Abbexa, abx345450

Rabies Virus Protein C (RABV C) Antibody (Biotin) is a Rabbit Polyclonal antibody conjugated to Biotin for the detection of Rabies virus C.

Rabies Virus Matrix Protein (RABV M) Antibody (HRP), Abbexa, abx109187

Rabies Virus Matrix Protein (RABV M) Antibody (HRP) is a Rabbit Polyclonal antibody against Rabies Virus Matrix Protein (RABV M) conjugated to HRP.

Anti-Rabies virus/RABV G/Glycoprotein Polyclonal Antibody, AntibodySystem, PVV03901

Anti-Rabies virus G/Glycoprotein Antibody (17C7) (VK584013), abinScience, VK584013

Anti-Rabies Virus (RV) Glycoprotein (G) Dog IgG ELISA Kit, ProteoGenix, KPTX434

Description of Anti-Rabies Virus (RV) Glycoprotein (G) Dog IgG ELISA Kit Understanding the Structure and Function of Anti-Rabies Virus Glycoprotein Dog IgG ELISA Kit The Anti-Rabies Virus (RV) Glycoprotein (G) Dog IgG ELISA Kit is a valuable tool for the detection and quantification of anti-RV glycoprotein antibodies in canine serum samples. This kit is designed to specifically target the glycoprotein (G) of the rabies virus, which is the main antigen responsible for inducing an immune response in infected animals. In this article, we will explore the structure, activity, and applications of this ELISA kit in detail. Structure of Anti-Rabies Virus Glycoprotein Dog IgG ELISA Kit The Anti-Rabies Virus Glycoprotein Dog IgG ELISA Kit is composed of several components that work together to accurately detect and measure anti-RV glycoprotein antibodies in canine serum samples. The main components of this kit include: Coated microplate: This is a 96-well microplate that is pre-coated with purified RV glycoprotein antigen. The antigen is immobilized on the surface of the plate, allowing for the specific binding of anti-RV glycoprotein antibodies present in the serum sample. Detection antibody: This is a biotinylated anti-dog IgG antibody that specifically binds to the anti-RV glycoprotein antibodies captured on the microplate. Streptavidin-HRP conjugate: This enzyme conjugate binds to the biotinylated detection antibody and produces a colorimetric signal upon reaction with the substrate. Substrate solution: This solution contains a chromogenic substrate that reacts with the enzyme conjugate to produce a color change, which can be measured using a microplate reader. Activity of Anti-Rabies Virus Glycoprotein Dog IgG ELISA Kit The Anti-Rabies Virus Glycoprotein Dog IgG ELISA Kit works on the principle of indirect ELISA. When a serum sample is added to the coated microplate, the anti-RV glycoprotein antibodies present in the sample will bind to the immobilized antigen. After washing away any unbound components, the biotinylated detection antibody is added, which binds to the captured antibodies. The addition of the streptavidin-HRP conjugate and substrate solution results in the production of a color change, which is directly proportional to the amount of anti-RV glycoprotein antibodies present in the sample. The color intensity can be measured using a microplate reader, and the results can be compared to a standard curve to determine the concentration of anti-RV glycoprotein antibodies in the sample. Applications of Anti-Rabies Virus Glycoprotein Dog IgG ELISA Kit The Anti-Rabies Virus Glycoprotein Dog IgG ELISA Kit has several applications in both research and clinical settings. Some of the key applications of this kit include: Therapeutic Target: The glycoprotein (G) of the rabies virus is a major therapeutic target for the development of vaccines and antiviral drugs. The Anti-Rabies Virus Glycoprotein Dog IgG ELISA Kit can be used to measure the levels of anti-RV glycoprotein antibodies in vaccinated animals, providing valuable data for the evaluation of vaccine efficacy. It can also be used to monitor the immune response in animals receiving antiviral treatments. Research Use: The Anti-Rabies Virus Glycoprotein Dog IgG ELISA Kit is an essential tool for researchers studying the epidemiology and pathogenesis of rabies virus infections in canines. It can be used to screen large numbers of serum samples from different geographical regions, allowing for the identification of areas with a high prevalence of the virus. This kit can also be used to study the kinetics of the immune response in infected animals, providing insights into the progression of the disease.

Anti-Rabies Virus (RV) Glycoprotein (G) Human IgA ELISA Kit, ProteoGenix, KPTX432

Description of Anti-Rabies Virus (RV) Glycoprotein (G) Human IgA ELISA Kit Introduction Anti-Rabies Virus (RV) Glycoprotein (G) Human IgA ELISA Kit is a powerful tool used in the detection and quantification of human IgA antibodies against the Glycoprotein (G) of the Rabies Virus. This kit is designed for research use and is not intended for diagnostic or therapeutic purposes. Structure of Anti-Rabies Virus (RV) Glycoprotein (G) The Rabies Virus Glycoprotein (G) is a type I transmembrane protein consisting of 505 amino acids. It is a major surface antigen of the virus and is responsible for inducing the production of neutralizing antibodies. The G protein is composed of a cytoplasmic tail, a transmembrane domain, and an ectodomain. The ectodomain is further divided into two regions: the N-terminal globular head domain and the C-terminal stem region. Activity of Anti-Rabies Virus (RV) Glycoprotein (G) The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgA ELISA Kit detects and measures the levels of human IgA antibodies against the G protein of the Rabies Virus. These antibodies play a crucial role in neutralizing the virus and preventing its spread within the body. Upon infection, the G protein binds to the acetylcholine receptor on nerve cells, facilitating viral entry and replication. However, the presence of neutralizing IgA antibodies can block this interaction, preventing infection and disease progression. Application of Anti-Rabies Virus (RV) Glycoprotein (G) Human IgA ELISA Kit The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgA ELISA Kit is a valuable tool for research in the field of rabies virus infection. It can be used to study the immune response to the virus and evaluate the efficacy of potential vaccines. Additionally, this kit can also aid in the diagnosis of rabies virus infection in non-human animals, such as dogs and cats, by detecting the presence of anti-RV IgA antibodies in their sera. Therapeutic Target The G protein of the Rabies Virus is a promising therapeutic target for the development of antiviral drugs. The ability of this protein to interact with host cells and facilitate viral entry makes it an ideal target for blocking viral infection. The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgA ELISA Kit can be used to screen potential therapeutic agents that can disrupt the interaction between the G protein and host cells, thereby inhibiting viral entry and replication. Research Use The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgA ELISA Kit is widely used in research studies to understand the immune response to the Rabies Virus. It can be used to monitor the levels of IgA antibodies against the G protein in serum samples from individuals who have been vaccinated against rabies or have been exposed to the virus. This kit can also aid in the development of new diagnostic methods and vaccines for rabies virus infection. Conclusion In conclusion, the Anti-Rabies Virus (RV) Glycoprotein (G) Human IgA ELISA Kit is a valuable tool for research use in the study of rabies virus infection. It provides a sensitive and specific method for the detection and quantification of human IgA antibodies against the G protein of the virus. This kit has multiple applications in the fields of therapeutic target identification, drug development, and vaccine research, making it an essential tool for advancing our understanding and management of rabies virus infection.

Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit, ProteoGenix, KPTX431

Description of Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit Introduction The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit is a scientific tool used for the detection and measurement of human IgG antibodies against the rabies virus glycoprotein. This kit is designed for research purposes and is not intended for diagnostic use. In this article, we will discuss the structure, activity, and applications of this ELISA kit. Structure of Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit consists of several components, including a microplate coated with recombinant rabies virus glycoprotein, a set of standards and controls, and reagents for sample preparation and detection. The microplate is coated with the recombinant glycoprotein to capture the human IgG antibodies present in the sample. The standards and controls are used to generate a standard curve for the quantification of the IgG antibodies. The reagents for sample preparation and detection include buffers, wash solutions, and enzyme-conjugated secondary antibodies. Activity of Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit works on the principle of the enzyme-linked immunosorbent assay (ELISA). The first step of the assay is the coating of the microplate with the recombinant glycoprotein. Next, the sample, standards, and controls are added to the microplate and allowed to incubate. During this incubation, any human IgG antibodies present in the sample will bind to the coated glycoprotein. After washing away any unbound components, the enzyme-conjugated secondary antibody is added. This secondary antibody will bind to the captured human IgG antibodies. Finally, a substrate solution is added, which will react with the enzyme and produce a color change. The intensity of the color is directly proportional to the amount of human IgG antibodies present in the sample, as determined by the standard curve. Therapeutic Target Rabies is a deadly viral disease that affects the central nervous system. It is primarily transmitted through the bite of an infected animal. The main therapeutic target of the Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit is to detect and measure the levels of human IgG antibodies against the rabies virus glycoprotein. These antibodies are produced by the immune system in response to a rabies virus infection. Early detection and measurement of these antibodies can help in the diagnosis and treatment of rabies. Research Use The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit is primarily used for research purposes. It is a valuable tool for studying the immune response to rabies virus infection and for developing new treatments and vaccines for rabies. The kit can also be used to monitor the effectiveness of rabies vaccines and to evaluate the immune status of individuals who have been exposed to the virus. Applications of Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgG ELISA Kit has several applications in the field of rabies research. Some of the key applications include: Detection of human IgG antibodies against rabies virus glycoprotein: The kit can be used to detect and measure the levels of human IgG antibodies in response to a rabies virus infection. This can aid in the diagnosis and treatment of rabies. Monitoring immune response to rabies virus infection: The kit can be used to monitor the immune response to rabies virus infection, which can provide valuable insights into the pathogenesis of the disease. Evaluation of vaccine efficacy: The kit can be used